Efroze Chemical Industries (Pvt.) Ltd., known as “The Heart Care Company” started its voyage of zeal in 1968 with the mission of striving towards better health for individuals and today it is recognized as a Quality Pharmaceuticals Manufacturer with an uninterrupted track-record of glazing the customer’s trustworthiness by advancing the quality of products as well as by frequently introducing the new and innovative molecules in the market.
Efroze has emerged as a four times proud holder of the FPCCI Special Merit Export Trophy by successfully exporting its pharmaceutical products in 17 countries and has established a very well defined marketing structure. Efroze is the only National pharmaceutical company whose Quality Control Laboratory is ISO-17025 accredited.
Obligation of Efroze towards improving the quality of life is continued by chasing the crucial needs of suffering people. The successful launch of CORBIS (Bisoprolol Fumarate) and its striking customer’s feedback has visibly enlightened the fact that there is an immense desire of the low dose composition addressing an intact problem in a fixed-dose form in managing uncomplicated / complicated hypertension.
In continuation of its tradition, Efroze (first time in Pakistan) is proud to commence another unique formulation i.e., Bisoprolol Fumarate + Hydrochlorothiazide with the brand name of CORBIS-H. This unique low dose composition of a Cardio Selective Beta Blocker and a Diuretic is principally the accumulated upshot of high degree efficacy, low incidence of side effects and high patient compliance. This combination is available internationally and has gained huge success in the management of hypertension.
The launch ceremony of CORBIS-H (Bisoprolol Fumarate + Hydrochlorothiazide) was held recently at Efroze head office in Karachi followed by a special presentation as a dedication to the higher management of the company.
The training session was initiated by Nadir Khan Feroz, Director Marketing & Sales. He enlightened the future vision and mission of the company and particularly appreciated the foresightedness of Khaliq-ur-Rehman, General Manager Marketing & Sales and the story behind the development of CORBIS-H (Bisoprolol Fumarate + Hydrochlorothiazide) in the form of a brief presentation in order to make team to realize the efforts behind the launch of CORBIS-H. In the end of his inspiring speech he also motivated the field force to move forward and to achieve individual tasks.
Muhammad Abdullah Feroz, Managing Director on his part added some appreciating words on the bravura victory of Delaware (Carvedilol), Angiotan (Valsartan) and Isotab (Isosorbide-5-Mononitrate) for the Marketing & Sales team. He also addressed the addition of the new product CORBIS-H to the Efroze Family.
Khaliq-ur-Rehman, General Manager Marketing & Sales addressed the purpose of the session and revealed the essential need of the superb low dose combination of CORBIS-H (Bisoprolol Fumarate + Hydrochlorothiazide).
In the end, the cake cutting ceremony of CORBIS-H was held with all the team members of Marketing & Sales, NPD, IMD, Production & Supply chain followed by refreshments.
Dr. Saifullah Awan, Product Manager and Amjad Hussain, Country Sales Manager conducted comprehensive two days training session including quiz & detailing contest. All the team members actively participated in the session under the supervision and guidance of Mr. Khaliq-ur-Rehman, General Manager Marketing & Sales.
Throughout the successful training session the team spirit was elevated and everyone seemed completely geared up to take a very good start with a lot of liveliness and passion.